Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

NCT05625893 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Portal Vein Thrombosis

Interventions

RADIATION: PBT and atezolizumab/bevacizumab

Sponsor

Samsung Medical Center